Testing effectiveness (Phase 2)Study completedNCT00430534
What this trial is testing
Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).
Who this might be right for
Epstein Barr Virus (EBV) Infection
Henogen 200